Full Text View
Tabular View
No Study Results Posted
Related Studies
Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish
This study is ongoing, but not recruiting participants.
Study NCT01412346   Information provided by National Institute for Health and Welfare, Finland

First Received on August 3, 2011.   Last Updated on June 18, 2012   History of Changes

August 3, 2011
June 18, 2012
January 2011
June 2012   (final data collection date for primary outcome measure)
Change from baseline in systolic and diastolic blood pressure after treatments [ Time Frame: 12 and 20 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01412346 on ClinicalTrials.gov Archive Site
  • Change from baseline in PFA-100 measurements after treatments [ Time Frame: 12 and 20 weeks ] [ Designated as safety issue: No ]
  • Change from baseline in biomarkers of cardiovascular disease risk after treatments [ Time Frame: 12 and 20 weeks ] [ Designated as safety issue: No ]
  • Change from baseline in nutritional biomarkers after treatments [ Time Frame: 12 and 20 weeks ] [ Designated as safety issue: No ]
  • Change from baseline in blood cell gene expression after treatments [ Time Frame: 12 and 20 weeks ] [ Designated as safety issue: No ]
Same as current
 
 
 
Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish
Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish

The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake.

The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).

 
Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Prehypertension
  • Hypertension
Other: Health effects of a Nordic diet rich in plant-based foods and fish
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.
  • Active Comparator: Plant-based food and fish with salt restriction
    The subjects consume plant based foods (fruits, berries, vegetables, whole grain) and fish in addition to a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).
    Intervention: Other: Health effects of a Nordic diet rich in plant-based foods and fish
  • Placebo Comparator: Diet with salt restriction
    The subjects follow a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).
    Intervention: Other: Health effects of a Nordic diet rich in plant-based foods and fish
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
120
June 2012
June 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)

Exclusion Criteria:

  • smoking
  • regular use of medications
  • intestinal disorders
  • symptomatic cardiovascular disease
  • obesity (BMI>35 kg/m2)
  • vegetarianism
  • high intake of alcohol
  • allergy to fish
  • pregnancy
Both
45 Years to 75 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Finland
 
NCT01412346
NPHIKTL_022011
No
Iris Erlund, National Institute for Health and Welfare, Finland
National Institute for Health and Welfare, Finland
  • Academy of Finland
  • University of Oslo
Study Director: Iris Erlund, Dr. National Institute for Health and Welfare, Finland
Study Director: Antti Jula, Dr. National Institute for Health and Welfare, Finland
National Institute for Health and Welfare, Finland
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP